BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3000087)

  • 1. [Mathematical planning of an experiment for assessing the combined action of new interferon inducers].
    Saĭitkulov AM; Chizhov NP; Churnosov EV; Ershov FI
    Vopr Virusol; 1985; 30(5):617-9. PubMed ID: 3000087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective action of double-stranded complexes--interferon inducers in encephalomyocarditis in mice].
    Nosik NN; Lavrukhina LA; Ershov FI
    Biull Eksp Biol Med; 1984 Apr; 97(4):446-8. PubMed ID: 6326886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bis-basic-substituted polycyclic aromatic compounds. A new class of antiviral agents. 1,2 6. Bis-basic-substituted fluoranthenes.
    Albrecht WL; Fleming RW; Horgan SW; Deck BA; Hoffman JW; Mayer GD
    J Med Chem; 1974 Nov; 17(11):1150-6. PubMed ID: 4369817
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance.
    Kern ER; Glasgow LA; Overall JC
    Proc Soc Exp Biol Med; 1976 Jul; 152(3):372-6. PubMed ID: 181760
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combined use of isoprinosine and an interferon inducer in experimental viral infection].
    Fomina AN; Grigorian SS; Nikolaeva OV; Ershov FI
    Antibiotiki; 1980 Nov; 25(11):854-7. PubMed ID: 6160806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of benzo(c)fluorene. VI. Antiviral and interferon-inducing activities of three benzo(c)fluorenone derivatives in mice.
    Smejkal F; Zelená D; Krepelka J; Vancurová I
    Acta Virol; 1985 Jan; 29(1):11-8. PubMed ID: 2859757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of low-molecular interferon inducers in experimental hepatitis in mice].
    Tazulakhova EB; Saĭitkulov AM; Barinskiĭ IF; Ershov FI
    Vopr Virusol; 1988; 33(2):179-81. PubMed ID: 2457987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of murine interferon by a substituted pyrimidine.
    Nichol FR; Weed SD; Underwood GE
    Antimicrob Agents Chemother; 1976 Mar; 9(3):433-9. PubMed ID: 176934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Double-stranded RNA from phage F6: its interferon-inducing and antiviral properties].
    Nosik NN; Pugachev VG; Ershov FI
    Antibiot Khimioter; 1990 Mar; 35(3):25-7. PubMed ID: 1694424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and examination of cytokine interactions by the median-effect model: an example with antiviral action of tumor necrosis factor and interferon-gamma.
    Abu-Khabar KS; Armstrong JA; Ho M
    J Interferon Res; 1992 Jun; 12(3):161-5. PubMed ID: 1322438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of interferon inducers in experimental influenza].
    Ershov FI; Moshchik KV
    Vopr Virusol; 1984; 29(6):706-7. PubMed ID: 6084899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic activity of the combined use of an interferon inducer and vaccine in experimental rabies].
    Gribencha SV; Nosik NN; Ershov FI; Barinskiĭ IF
    Vopr Virusol; 1983; 28(5):590-4. PubMed ID: 6659475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mathematical modelling of the effect of interferon inducers on the development of a viral infection].
    Chizhov NP; Churnosov EV
    Vopr Virusol; 1988; 33(1):94-8. PubMed ID: 3369151
    [No Abstract]   [Full Text] [Related]  

  • 14. [Natural interferon inducers: double-stranded RNA of killer plasmids of Saccharomyces cerevisiae].
    Duzhak AB; Kostomakha AN; Lobova NN; Podgornyĭ VF; Nosik NN
    Antibiot Med Biotekhnol; 1985 Jan; 30(1):19-21. PubMed ID: 2986543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of interferons produced by different cell populations.
    Nossik NN; Bopegamage SA; Yershov FI
    Acta Microbiol Hung; 1988; 35(4):397-403. PubMed ID: 2469281
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biological characteristics of new interferon inducers created on a gossypol base].
    Saĭitkulov AM; Tazulakhova EB; Sarymsakov AA; Ershov FI
    Vopr Virusol; 1984; 29(6):749-51. PubMed ID: 6084903
    [No Abstract]   [Full Text] [Related]  

  • 17. [Outlook on the use of interferon and its inducers in preventing influenza].
    Ershov FI; Moshchik KV
    Vopr Virusol; 1985; 30(4):388-93. PubMed ID: 2414924
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of interferon inducers on chemically-induced mutagenesis and carcinogenesis].
    Loginova NS; Kinzirskiĭ AS; Parshina OV; Mirskaia EE; Ershov FI
    Vestn Ross Akad Med Nauk; 1996; (3):28-33. PubMed ID: 8672957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combined use of interferon inducers and recombinant influenza viruses for protection from the disease].
    Podcherniaeva RIa; Shchipanova MV; Nosik NN; Ershov FI; L'vov DK
    Vopr Virusol; 1984; 29(2):173-5. PubMed ID: 6203227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of herpetic keratitis with interferon and its inducer in an experiment].
    Bostandzhian MG; Nurmamedov NN; Annanepesov IaKh; Nazarov RO
    Vestn Oftalmol; 1987; 103(3):57-9. PubMed ID: 2442876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.